Premium
When Singapore sovereign wealth fund Temasek Holdings came in as a new investor in Dr Agarwal’s Health Care Ltd earlier this year, India’s eye-care industry emerged from an extended period of private equity lull and a whiff of gloom largely induced by the financial controversy surrounding Vasan Healthcare Pvt. Ltd ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
